3-(6-Chloro-5-fluoro-4-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride (1:1)(CAS: 188416-20-8)

This compound is subject to various regulatory guidelines including GHS classification for hazardous substances, REACH regulations in the European Union, and FDA/EPA requirements for chemical substances used in pharmaceuticals and environmental safety. Manufacturers and importers must comply with these regulations for proper labeling, storage, and handling.

Alternative reagents such as 5-fluoro-6-chloro-4-pyrimidinyl derivatives and substituted triazoles can be used as alternatives. Isomers and analogs like 4-chloro-5-fluoro-6-pyrimidinyl derivatives can also be explored depending on the specific synthetic pathway requirements.

The market trend for this compound is growing due to its potential applications in pharmaceuticals, particularly as an intermediate in drug synthesis. Research trends focus on its anti-tumor and anti-inflammatory properties, with increasing interest in its use as a novel therapeutic agent. Price trends indicate steady demand with minor fluctuations based on production costs and market supply.

Waste containing this compound should be collected in appropriate containers, labeled as hazardous, and disposed of through professional waste management services. Incineration or chemical treatment methods are commonly used for safe disposal. Environmental precautions include ensuring no leakage and proper containment to prevent soil and water contamination.